Table of Contents Author Guidelines Submit a Manuscript
Pain Research and Treatment
Volume 2014 (2014), Article ID 518716, 15 pages
http://dx.doi.org/10.1155/2014/518716
Research Article

Clinical Characteristics, Patient-Reported Outcomes, and Previous Therapeutic Management of Patients with Uncontrolled Neuropathic Pain Referred to Pain Clinics

1Anesthesia, Critical Care, and Multidisciplinary Pain Management Department, Valencia University General Hospital, Valencia University Medical School, Valencia, Spain
2Pain Unit, Hospital Ramón y Cajal, Madrid, Spain
3Medical Unit, Pfizer España, Avenida de Europa, 20 B Parque Empresarial La Moraleja, 28108 Alcobendas, Madrid, Spain

Received 26 September 2013; Revised 7 April 2014; Accepted 7 April 2014; Published 5 May 2014

Academic Editor: Robert L. Barkin

Copyright © 2014 José de Andrés et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. D. Treede, T. S. Jensen, J. N. Campbell et al., “Neuropathic pain: redefinition and a grading system for clinical and research purposes,” Neurology, vol. 70, no. 18, pp. 1630–1635, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Torrance, B. H. Smith, M. I. Bennett, and A. J. Lee, “The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey,” Journal of Pain, vol. 7, no. 4, pp. 281–289, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Bouhassira, M. Lantéri-Minet, N. Attal, B. Laurent, and C. Touboul, “Prevalence of chronic pain with neuropathic characteristics in the general population,” Pain, vol. 136, no. 3, pp. 380–387, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Pérez, M. T. Saldaña, A. Navarro, I. Vilardaga, and J. Rejas, “Prevalence and characterization of neuropathic pain in a primary-care setting in spain: a cross-sectional, multicentre, observational study,” Clinical Drug Investigation, vol. 29, no. 7, pp. 441–450, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. G. T. Carter and B. S. Galer, “Advances in the management of neuropathic pain,” Physical Medicine and Rehabilitation Clinics of North America, vol. 12, no. 2, pp. 447–459, 2001. View at Google Scholar · View at Scopus
  6. R. Baron, A. Binder, and G. Wasner, “Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment,” The Lancet Neurology, vol. 9, no. 8, pp. 807–819, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. G. W. Jay and R. L. Barkin, “Neuropathic pain: etiology, pathophysiology, mechanisms, and evaluations,” Disease-a-Month, vol. 60, pp. 6–47, 2014. View at Publisher · View at Google Scholar
  8. M. Gore, N. A. Brandenburg, D. L. Hoffman, K.-S. Tai, and B. Stacey, “Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives,” Journal of Pain, vol. 7, no. 12, pp. 892–900, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Gálvez, C. Marsal, J. Vidal, M. Ruiz, and J. Rejas, “Cross-sectional evaluation of patient functioning and health-related quality of life in patients with neuropathic pain under standard care conditions,” European Journal of Pain, vol. 11, no. 3, pp. 244–255, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. A. M. McDermott, T. R. Toelle, D. J. Rowbotham, C. P. Schaefer, and E. M. Dukes, “The burden of neuropathic pain: results from a cross-sectional survey,” European Journal of Pain, vol. 10, no. 2, pp. 127–135, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Attal, M. Lanteri-Minet, B. Laurent, J. Fermanian, and D. Bouhassira, “The specific disease burden of neuropathic pain: results of a French nationwide survey,” Pain, vol. 152, no. 12, pp. 2836–2843, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. B. H. Smith and N. Torrance, “Epidemiology of neuropathic pain and its impact on quality of life,” Current Pain and Headache Reports, vol. 16, pp. 191–198, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. M. J. Rodríguez and A. J. García, “A registry of the aetiology and costs of neuropathic pain in pain clinics: results of the registry of aetiologies and costs (REC) in neuropathic pain disorders study,” Clinical Drug Investigation, vol. 27, no. 11, pp. 771–782, 2007. View at Google Scholar · View at Scopus
  14. A. Berger, E. M. Dukes, and G. Oster, “Clinical characteristics and economic costs of patients with painful neuropathic disorders,” Journal of Pain, vol. 5, no. 3, pp. 143–149, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. P. C. Langley, C. Van Litsenburg, J. C. Cappelleri, and D. Carroll, “The burden associated with neuropathic pain in Western Europe,” Journal of Medical Economics, vol. 16, pp. 85–95, 2013. View at Google Scholar
  16. N. Attal, G. Cruccu, R. Baron et al., “EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision,” European Journal of Neurology, vol. 17, no. 9, pp. 1113–1188, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Harden and M. Cohen, “Unmet needs in the management of neuropathic pain,” Journal of Pain and Symptom Management, vol. 25, pp. S12–S17, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Gore, E. Dukes, D. J. Rowbotham, K. S. Tai, and D. Leslie, “Clinical characteristics and pain management among patients with painful peripheral neuropathic disorders in general practice settings,” European Journal of Pain, vol. 11, no. 6, pp. 652–664, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. National Institute for Health Clinical Excellence, “Neuropathic pain: the pharmacological management of neuropathic pain in adults in non-specialist settings,” in NICE Clinical Guideline, National Institute for Health and Clinical Excellence, London, 96th edition, 2010. View at Google Scholar
  20. R. H. Dworkin, A. B. O'Connor, J. Audette et al., “Recommendations for the pharmacological management of neuropathic pain: an overview and literature update,” Mayo Clinic Proceedings, vol. 85, pp. S3–S14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. R. S. Taylor, “Epidemiology of refractory neuropathic pain,” Pain Practice, vol. 6, no. 1, pp. 22–26, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Bouhassira, N. Attal, H. Alchaar et al., “Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4),” Pain, vol. 114, no. 1-2, pp. 29–36, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Bouhassira, N. Attal, J. Fermanian et al., “Development and validation of the neuropathic pain symptom inventory,” Pain, vol. 108, no. 3, pp. 248–257, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Perez, R. Galvez, S. Huelbes et al., “Validity and reliability of the Spanish version of the DN4 (Douleur Neuropathique 4 questions) questionnaire for differential diagnosis of pain syndromes associated to a neuropathic or somatic component,” Health and Quality of Life Outcomes, vol. 5, article 66, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. A. S. Zigmond and R. P. Snaith, “The hospital anxiety and depression scale,” Acta Psychiatrica Scandinavica, vol. 67, no. 6, pp. 361–370, 1983. View at Google Scholar · View at Scopus
  26. M. J. Herrero, J. Blanch, J. M. Peri, J. de Pablo, L. Pintor, and A. Bulbena, “A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population,” General Hospital Psychiatry, vol. 25, no. 4, pp. 277–283, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. R. D. Hays and A. L. Stewart, “Sleep measures,” in Measuring Functioning and Well-Being: The Medical Outcomes Study Approach, A. L. Stewart and J. E. Ware, Eds., pp. 235–259, Duke University Press, Durham, NC, USA, 1992. View at Google Scholar
  28. J. Rejas, M. V. Ribera, M. Ruiz, and X. Masrramón, “Psychometric properties of the MOS (Medical Outcomes Study) Sleep Scale in patients with neuropathic pain,” European Journal of Pain, vol. 11, no. 3, pp. 329–340, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. World Health Organization, World Health Organization Disability Assessment Schedule II. 12-Item Self-Administered Version, World Health Organization, Geneve, Switzerland, 2004.
  30. J. V. Luciano, J. L. Ayuso-Mateos, A. Fernández, A. Serrano-Blanco, M. Roca, and J. M. Haro, “Psychometric properties of the twelve item World Health Organization Disability Assessment Schedule II (WHO-DAS II) in Spanish primary care patients with a first major depressive episode,” Journal of Affective Disorders, vol. 121, no. 1-2, pp. 52–58, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. J. L. Vázquez-Barquero, E. Vázquez Bourgón, S. Herrera Castanedo et al., “Spanish version of the new World Health Organization Disability Assessment Schedule II, (WHO-DAS-II): initial phase of development and pilot study,” Actas Espanolas de Psiquiatria, vol. 28, no. 2, pp. 77–87, 2000. View at Google Scholar · View at Scopus
  32. J. Rejas, M. A. Ruiz, A. Pardo, and J. Soto, “Minimally important difference of the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q),” BMC Medical Research Methodology, vol. 11, article 142, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. M. A. Ruiz, A. Pardo, J. Rejas, J. Soto, F. Villasante, and J. L. Aranguren, “Development and validation of the “treatment satisfaction with medicines questionnaire” (SATMED-Q),” Value in Health, vol. 11, no. 5, pp. 913–926, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Fricker, “Pain in Europe,” A Report, 2012. View at Google Scholar
  35. “Practice guidelines for cancer pain management. A report by the American Society of Anesthesiologists Task Force on Pain Management, Cancer Pain Section,” Anesthesiology, vol. 84, no. 5, pp. 1243–1257, 1996. View at Publisher · View at Google Scholar
  36. C. E. Argoff, “The coexistence of neuropathic pain, sleep, and psychiatric disorders: a novel treatment approach,” The Clinical journal of pain, vol. 23, no. 1, pp. 15–22, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Gore, N. A. Brandenburg, E. Dukes, D. L. Hoffman, K.-S. Tai, and B. Stacey, “Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep,” Journal of Pain and Symptom Management, vol. 30, no. 4, pp. 374–385, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Jain, S. Jain, C. L. Raison, and V. Maletic, “Painful diabetic neuropathy is more than pain alone: examining the role of anxiety and depression as mediators and complicators,” Current Diabetes Reports, vol. 11, no. 4, pp. 275–284, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. P. C. Emery, K. G. Wilson, and J. Kowal, “Major depressive disorder and sleep disturbance in patients with chronic pain,” Pain Res Manag, vol. 19, pp. 35–41, 2014. View at Google Scholar
  40. L. Gormsen, R. Rosenberg, F. W. Bach, and T. S. Jensen, “Depression, anxiety, health-related quality of life and pain in patients with chronic fibromyalgia and neuropathic pain,” European Journal of Pain, vol. 14, no. 127, pp. 127.e1–127.e8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. K. G. Wilson, M. Y. Eriksson, J. L. D'Eon, S. F. Mikail, and P. C. Emery, “Major depression and insomnia in chronic pain,” Clinical Journal of Pain, vol. 18, no. 2, pp. 77–83, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. M. T. Smith and J. A. Haythornthwaite, “How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature,” Sleep Medicine Reviews, vol. 8, no. 2, pp. 119–132, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Cornwall and D. C. Donderi, “The effect of experimentally induced anxiety on the experience of pressure pain,” Pain, vol. 35, no. 1, pp. 105–113, 1988. View at Google Scholar · View at Scopus
  44. S. Boogaard, M. W. Heymans, J. Patijn et al., “Predictors for persistent neuropathic pain—a delphi survey,” Pain Physician, vol. 14, no. 6, pp. 559–568, 2011. View at Google Scholar · View at Scopus
  45. B. McCarberg and R. Billington, “Consequences of neuropathic pain: quality-of-life issues and associated costs,” The American Journal of Managed Care, vol. 12, pp. S263–S268, 2006. View at Google Scholar · View at Scopus
  46. V. Bril, J. England, G. M. Franklin et al., “Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation,” Neurology, vol. 76, no. 20, pp. 1758–1765, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. D. E. Moulin, A. J. Clark, I. Gilron et al., “Pharmacological management of chronic neuropathic pain—consensus statement and guidelines from the canadian pain society,” Pain Research and Management, vol. 12, no. 1, pp. 13–21, 2007. View at Google Scholar · View at Scopus
  48. J. P. Dieleman, J. Kerklaan, F. J. Huygen, P. A. Bouma, and M. C. J. M. Sturkenboom, “Incidence rates and treatment of neuropathic pain conditions in the general population,” Pain, vol. 137, no. 3, pp. 681–688, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Berger, A. Sadosky, E. Dukes, J. Edelsberg, and G. Oster, “Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study,” BMC Neurology, vol. 12, article 8, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Tölle, E. Dukes, and A. Sadosky, “Patient burden of trigeminal neuralgia: results from a cross-sectional survey of health state impairment and treatment patterns in six European countries,” Pain Practice, vol. 6, no. 3, pp. 153–160, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Tölle, X. Xu, and A. B. Sadosky, “Painful diabetic neuropathy: a cross-sectional survey of health state impairment and treatment patterns,” Journal of Diabetes and its Complications, vol. 20, no. 1, pp. 26–33, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. B. H. Smith, N. Torrance, J. A. Ferguson et al., “Towards a definition of refractory neuropathic pain for epidemiological research. An international Delphi survey of experts,” BMC Neurology, vol. 12, article 29, 2012. View at Publisher · View at Google Scholar